V
Velarion™Intelligence
Sign InFree TrialBook a Walkthrough
MedTech & Diagnostics

Inogen Executive Compensation (FY25)

INGN · Executive and director compensation, fiscal 2022 to 2025
Chief executive, fiscal 2025
◇
Kevin R.M. Smith
Latest say-on-pay support
=
April 6, 2026
Chief executive pay ratio
◇
To the median employee
Velarion Member: every covered company in MedTech & Diagnostics, with dashboards, peer screens and board-ready briefs. Three seats, one year.

The Inogen brief, $1,500

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $499 for the board report; $2,400 for both.
Get the executive briefGet the board briefNo account needed.
Data as of October 19, 2026Latest filing (8-K): June 11, 2026
7 filings cited on this page
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Inogen brief$1,500Get the executive brief
Velarion Member, one year
194 figures on this page: 192 cited to the filing that reported them, 2 calculated from figures it prints. See the citations
What changed from fiscal 2024 to fiscal 2025
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive total compensation — Kevin R.M. Smith: $4,159,779 → $2,613,804 (37.2% lower)
Say-on-pay support: 90.8% → 94.8% (4.0 points higher)
CEO pay ratio: 53:1 → 35:1 (34.0% lower)

Frequently asked questions

Answers drawn from the data on this page.
Who is Inogen's chief executive and what were they paid?
Kevin R.M. Smith, Chief Executive Officer and President, Director, received $2,613,804 in total compensation for fiscal 2025. Smith's total moved 37.2% lower from the $4,159,779 reported for fiscal 2024.
What was Inogen's say-on-pay result?
The say-on-pay proposal drew 94.8% of votes cast including abstentions in favor at the meeting held April 6, 2026 for fiscal 2025.
Which companies are in Inogen's peer group?
Companies named in the disclosed peer group include Alphatec Holdings, Inc., AngioDynamics, Inc., Artivion, Inc., AtriCure, Inc. and Axogen, Inc., among others.
What is Inogen's chief executive pay ratio?
The company reported a chief executive pay ratio of 35:1 for fiscal 2025, against median employee compensation of $74,060.

Executive compensation

Every element reported for each named executive officer, by fiscal year.
Fiscal 2022
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Nabil Shabshab
Chief Executive Officer and President, Director
◇—◇—◇—◇◇
Stanislav Glezer
Executive Vice President, Chief Technology Officer
◇—◇—◇—◇◇
George Parr
Executive Vice President, Chief Commercial Officer
◇—◇—◇—◇◇
Kristin Caltrider
Executive Vice President, Finance and Chief Financial Officer
◇◇◇—◇—◇◇
Jason Somer
Executive Vice President, General Counsel and Corporate Secretary
◇—◇—◇—◇◇
Michael Sergesketter
Former Executive Vice President, Finance and Chief Financial Officer
Departed during or after this year
◇◇—————◇
Fiscal 2023
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Kevin R.M. Smith
Chief Executive Officer and President, Director
◇◇◇———◇◇
Fiscal 2024
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Kevin R.M. Smith
Chief Executive Officer and President, Director
◇◇◇—◇—◇◇
Michael Bourque
Former Executive Vice President, Chief Financial Officer, and Corporate Treasurer
◇◇◇—◇—◇◇
Stanislav Glezer
Former Executive Vice President, Chief Technology Officer
Departed during or after this year
◇—◇———◇◇
Gregoire Ramade
Executive Vice President, Chief Commercial Officer
◇———◇——◇
Fiscal 2025
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Kevin R.M. Smith
Chief Executive Officer and President, Director
◇—◇———◇◇
Michael Bourque
Former Executive Vice President, Chief Financial Officer, and Corporate Treasurer
Departed during or after this year
◇—◇—◇—◇◇
Jennifer Yi Boyer
Executive Vice President, Enterprise Enablement and Chief Human Resources Officer
◇—◇—◇—◇◇
Kevin Smith
Executive Vice President, General Counsel, Secretary and Business Development
◇—◇—◇—◇◇
Gregoire Ramade
Executive Vice President, Chief Commercial Officer
◇—◇—◇—◇◇
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.

Equity awards granted

Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2025
OfficerAwardGrant dateThreshold unitsTarget unitsUnits grantedMaximum unitsExercise priceGrant date fair value
Gregoire RamadePSU◇—◇—◇—◇
Gregoire RamadeRSU◇——◇——◇
Jennifer Yi BoyerPSU◇—◇—◇—◇
Jennifer Yi BoyerRSU◇——◇——◇
Kevin P. SmithRSU◇——◇——◇
Kevin P. SmithPSU◇—◇—◇—◇
Michael BourqueRSU◇——◇——◇
Michael BourquePSU◇—◇—◇—◇
Fiscal 2022, 2024 are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.

Outstanding awards

Awards still held at fiscal year end.
As disclosed at fiscal 2025 year end
OfficerAwardUnvested unitsMarket value of unvested unitsExercise priceExpires
Gregoire RamadeRSU◇◇——
RSU◇◇——
PSU◇◇——
Jennifer Yi BoyerPSU◇◇——
PSU◇◇——
RSU◇◇——
RSU◇◇——
PSU◇◇——
RSU◇◇——
Kevin SmithRSU◇◇——
PSU◇◇——
PSU◇◇——
RSU◇◇——
PSU◇◇——
RSU◇◇——
PSU◇◇——
RSU◇◇——
RSU◇◇——
Michael BourqueRSU◇◇——
PSU◇◇——
RSU◇◇——
PSU◇◇——
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Severance and change in control

The terms as written in the agreements.
Gregoire Ramade
Executive Vice President, Chief Commercial Officer · Terms as described in the company’s compensation discussion · citing a 2026 filing
Severance cash amount◇
Jennifer Yi Boyer
Executive Vice President, Enterprise Enablement and Chief Human Resources Officer · Terms as described in the company’s compensation discussion
Severance cash amount◇
Kevin R.M. Smith
Chief Executive Officer · Terms as described in the company’s compensation discussion · citing a 2026 filing
Severance cash amount◇
Kevin Smith
General Counsel · Terms as described in the company’s compensation discussion · citing a 2026 filing
Severance cash amount◇

Director compensation

What each non-employee director was paid.
Fiscal 2025
DirectorFees earned in cashStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Elizabeth Mora
Board chair
◇◇————◇
Mira Sahney
◇◇————◇
Mary Kay Ladone
◇◇————◇
Glenn Boehnlein
◇◇————◇
Kevin King
◇◇————◇
Heather Rider
◇◇————◇
Thomas A. West
◇—————◇
Kevin R.M. Smith and Vafa Jamali served on the board in fiscal 2025 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
Earlier years are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director fee schedule

The standing retainers and premiums the board pays, as published.
Board cash retainer◇
Board equity retainer◇
Total board retainer◇
Board chair premium◇
Audit committee chair◇
Audit committee member◇
Compensation committee chair◇
Compensation committee member◇
Nominating and governance chair◇
Nominating and governance member◇
Equity is delivered as restricted stock units.

Disclosed peer group

The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2025
  • Alphatec Holdings, Inc. ATEC
  • AngioDynamics, Inc. ANGO
  • Artivion, Inc. AORT
  • AtriCure, Inc. ATRC
  • Axogen, Inc. AXGN
  • Bioventus, Inc. BVS
  • Inari Medical, Inc. NARI
  • iRhythm Technologies, Inc. IRTC
  • Kewaunee Scientific Corporation KEQU
  • LeMaitre Vascular, Inc. LMAT
  • Nevro Corporation NVRO
  • OraSure Technologies, Inc. OSUR
  • STAAR Surgical Company STAA
  • Tactile Systems Technology, Inc. TCMD
  • TransMedics Group, Inc. TMDX
  • Treace Medical Concepts, Inc. TMCI
  • ZimVie, Inc. ZIMV
  • Zynex, Inc. ZYXI

Say-on-pay history

Shareholder support for the compensation program, by year.
YearMeetingSupportVotes forVotes againstAbstentions
2025April 6, 2026=◇◇◇
2024March 17, 2025=◇◇◇

Chief executive pay ratio

As calculated and reported by the company.
Ratio
◇
Median employee compensation
◇
Chief executive total compensation
◇

Velarion Pro: every company page, peer tools and exports, one seat

One seat, one person. It opens the whole platform: the peer tools, the written analysis and the exports, on every company we cover. Join the list and you will hear from us when it opens.
Your address is used for this and nothing else, and you can unsubscribe in one click. See the privacy policy.

Ask our research desk — $99, 24h, every figure cited to its filing.

Sample answer — “What is the CEO’s total compensation?”
- Kevin R.M. Smith (Chief Executive Officer and President, Director), FY2025 total compensation $2,613,804 (base salary $711,077) [exec_comp, SEC accession 0001294133-26-000009, filed 2026-04-28]

Answered within 24 hours, every figure cited to its SEC filing. If our database cannot answer your question, you are refunded automatically.

Email me this page as a cited PDF — sent in 2 minutes
The same figures, the same citations, formatted to hand to a committee. Nothing is added that is not on this page.
Your address is used for this and nothing else. Unsubscribe in one click.
Tell me when Inogen files
You get a note when this company’s compensation data changes.
Your address is used for this and nothing else. Unsubscribe in one click.

What this page does not include

Everything above is a fact Inogen disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where Inogen sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $1,500
Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $1,500
Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $499
Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion Intelligence
Adviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Inquire about access
Multiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion Intelligence
Join the list for Peer Group Review
Whether Inogen's disclosed peer group is defensible, who names Inogen back in their own benchmarking group, and how pay tracks performance across it. This is the analysis a compensation consultant delivers on the group above. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.

Citations

Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
194 figures on this page: 192 cited to the filing that reported them, 2 calculated from figures it prints.
192 cited to the filing
2 calculated from the filing

Documents cited

  1. 0001294133-26-000021
    Proposal No. 4 – Approval of the Amended and Restated 2023 Equity Incentive Plan,” which description is incorporated herein by reference.
  2. 0001294133-26-000009
    2025 Summary Compensation Table · CEO Pay Ratio Disclosure · Compensation Discussion and Analysis · Compensation Table · and 3 more sections
  3. 0000950170-25-099624
    Exhibit
  4. 0000950170-25-074437
    Proposal No. 4 – Approval of the Amended and Restated 2023 Equity Incentive Plan,” which description is incorporated herein by reference.
  5. 0000950170-25-045737
    Compensation Table · Summary Compensation Table
  6. 0000950170-24-045541
    Compensation Table
  7. 0000950170-23-013270
    2022 Summary Compensation Table
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “Inogen executive compensation, FY2022–FY2025.” https://intel.velarion.ai/comp/INGN (accessed 2026).
Short form: data: Velarion

The Inogen brief, $1,500

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $499 for the board report; $2,400 for both.
Get the executive briefGet the board briefNo account needed.
7 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about Inogen and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
Setup guide and the full list of questions it answers

MedTech & Diagnostics rankings

Chief executive pay — MedTech & DiagnosticsCEO pay ratio — MedTech & DiagnosticsSay-on-pay support — MedTech & Diagnostics

Peers Inogen discloses

The companies named in INGN's own disclosed peer group.

Alphatec Holdings, Inc.AngioDynamics, Inc.Artivion, Inc.AtriCure, Inc.Axogen, Inc.Bioventus, Inc.Inari Medical, Inc.iRhythm Technologies, Inc.Kewaunee Scientific CorporationLeMaitre Vascular, Inc.Nevro CorporationOraSure Technologies, Inc.STAAR Surgical CompanyTactile Systems Technology, Inc.TransMedics Group, Inc.Treace Medical Concepts, Inc.ZimVie, Inc.Zynex, Inc.

Terms on this page

Say-on-Pay VoteCEO Pay RatioMedian Employee CompensationAll companies

Free to read and cite. Redistribution or bulk use of the dataset requires a data license. Talk to us about the data license.

Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
  author = {{Velarion Company Intelligence}},
  title = {Velarion database: executive and board compensation data},
  year = {2026},
  version = {2026Q3},
  doi = {10.5281/zenodo.22283854},
  publisher = {Zenodo},
  url = {https://doi.org/10.5281/zenodo.22283854}
}
For informational purposes only. Not investment, legal, or compensation advice.  All companies · The Pay Desk · Methodology · Terms · Privacy